Novadip Biosciences SA
39.3 FTENovadip Biosciences reported total assets of €85.3m at the end of the 2025 financial year (annual accounts filed with the NBB on 14 Jul 2026), with 39.3 full-time equivalents.
By total assets for 2025, Novadip Biosciences ranks among the 50 largest of the 993 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Novadip Biosciences shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -23 % Total assets +17 % Headcount (avg FTE) +4 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Novadip Biosciences's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Jul 2026
- Year ended 31 Dec 2024filed on 10 Jul 2025
- Year ended 31 Dec 2023filed on 05 Jun 2024
- Year ended 31 Dec 2022filed on 08 Jun 2023
- Year ended 31 Dec 2021filed on 16 May 2022
Novadip Biosciences's financial analysis
- Solvency58.6%sector median: 57.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Novadip Biosciences
Novadip Biosciences's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0535.575.602
- VAT number
- BE0535575602
- Peppol
- Registered · 0208:0535575602 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 31 May 2013
- Registered office
- 1435 Mont-Saint-Guibert
- Size
- Small · 39.3 FTE
- Latest accounts
- 2025 · filed on 14 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Novadip Biosciences (SA) has been based in Mont-Saint-Guibert since 2013, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of €13.1m and equity of €50.0m; its revenue is not published. With 39.3 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 58.6%, above the median of its sector (57.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Novadip Biosciences
Companies in the same business, of comparable size and area, outside its group.
- iTeos Belgium Research and experimental development on natural sciences and engineering Charleroi · balance sheet €46.3m
- Devgen Research and experimental development on natural sciences and engineering Ghent · balance sheet €130.9m
- MDxHealth Research and experimental development on natural sciences and engineering Herstal · balance sheet €159.3m
- OSIVAX Belgique Research and experimental development on natural sciences and engineering Liège · balance sheet €17.0m
- Ncardia Holding Research and experimental development on natural sciences and engineering Mont-Saint-Guibert · balance sheet €108.4m
- Confo Therapeutics Research and experimental development on natural sciences and engineering Ghent · balance sheet €37.8m
- Belgian Volition Research and experimental development on natural sciences and engineering Gembloux · balance sheet €42.6m
- AgomAb Therapeutics Technical testing and analysis Antwerp · balance sheet €251.3m
Frequently asked questions about Novadip Biosciences
What is the revenue of Novadip Biosciences?
Novadip Biosciences files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Novadip Biosciences?
In Belgium, the VAT number is the company number prefixed with BE: BE0535575602 for Novadip Biosciences, if the company is VAT-registered. Its company number (CBE) is 0535.575.602.
Where is the registered office of Novadip Biosciences?
According to the CBE register, the registered office of Novadip Biosciences is in 1435 Mont-Saint-Guibert.
What is the equity of Novadip Biosciences?
At the close of the 2025 financial year, the equity of Novadip Biosciences amounts to 49,976,039 €, a solvency of 58.6% of total assets.
How many people work at Novadip Biosciences?
39.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Novadip Biosciences?
The register lists 14 active mandates at Novadip Biosciences. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Novadip Biosciences within its sector?
By total assets for 2025, Novadip Biosciences ranks among the 50 largest of the 993 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year.
The full file of Novadip Biosciences
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →